Last updated: January 24, 2025
Sponsor: Weill Medical College of Cornell University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Breast Cancer
Cancer
Treatment
Live Biobank
Clinical Study ID
NCT05134779
21-06023682
Ages 18-90 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- All patients will historically proven BC are eligible to be on the study
Exclusion
Exclusion Criteria:
- Carriers of other cancers other than breast.
Study Design
Total Participants: 400
Treatment Group(s): 1
Primary Treatment: Live Biobank
Phase:
Study Start date:
January 12, 2022
Estimated Completion Date:
December 31, 2028
Study Description
Connect with a study center
Brooklyn Methodist Hospital - NewYork Presbyterian
New York, New York 11215
United StatesActive - Recruiting
New York Presbyterian Hospital - Queens
New York, New York 11355
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.